Lee, Song-Yi https://orcid.org/0000-0001-9091-8242
Roh, Heegwang
Gonzalez-Perez, David https://orcid.org/0000-0001-9613-4705
Mackey, Mason R.
Hoces, Daniel https://orcid.org/0000-0002-1451-5166
McLaughlin, Colleen N.
Lin, Chang
Adams, Stephen R.
Nguyen, Khanh
Kim, Keun-Young
Luginbuhl, David J.
Luo, Liqun
Udeshi, Namrata D. https://orcid.org/0000-0001-5312-1402
Carr, Steven A. https://orcid.org/0000-0002-7203-4299
Hernández-López, Rogelio A.
Ellisman, Mark H.
Alcalde, Miguel https://orcid.org/0000-0001-6780-7616
Ting, Alice Y. https://orcid.org/0000-0002-8277-5226
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (RC2DK129964)
National Science Foundation (NeuroNex UTA20-000889)
Article History
Received: 5 September 2024
Accepted: 6 June 2025
First Online: 1 August 2025
Competing interests
: A.Y.T. is a scientific advisor to Third Rock Ventures and Nereid Therapeutics. The remaining authors declare no competing interests.